As of June 06, 2026, Exelixis's top three insider holders are Michael Morrissey (President And Ceo, 3.60Mn shares), Stelios Papadopoulos (Director, 1.19Mn shares), Christopher J. Senner (Evp And Cfo, 1.03Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| George Poste | - | 178,832 | 0 | 30 May, 2025 |
| Charles Cohen | - | 261,375 | 0 | 08 Jul, 2021 |
| Vincent T Marchesi | - | 93,989 | 0 | 27 May, 2022 |
| Michael Morrissey | President And Ceo | 1,614,552 | 1,989,956 | 02 Mar, 2026 |
| Stelios Papadopoulos | - | 1,189,228 | 0 | 13 Nov, 2025 |
| Lance Willsey | - | 424,415 | 0 | 13 May, 2022 |
| Gisela Schwab | Pres, Prod Dev Med Aff Cmo | 689,078 | 0 | 28 Jul, 2021 |
| Alan M Garber | - | 35,703 | 0 | 25 Mar, 2024 |
| Carl B Feldbaum | - | 18,701 | 0 | 10 Feb, 2023 |
| Peter Lamb | Evp, Scientific Strategy Cso | 410,958 | 0 | 16 Dec, 2022 |
| Mary C Beckerle | - | 21,380 | 0 | 13 Nov, 2025 |
| Maria C Freire | - | 100,819 | 0 | 30 May, 2025 |
| Jeffrey Hessekiel | Evp General Counsel | 693,396 | 0 | 16 May, 2025 |
| Christopher J. Senner | Evp And Cfo | 1,028,110 | 0 | 02 Mar, 2026 |
| Amy C. Peterson | Evp Prod Dev Med Aff Cmo | 465,393 | 0 | 16 May, 2025 |
| Patrick J. Haley | Evp, Commercial | 422,367 | 0 | 02 Mar, 2026 |
| Bob Oliver | - | 21,120 | 0 | 18 Feb, 2026 |
| Vicki L Goodman | Evp, Prod Dev Med Aff Cmo | 307,654 | 0 | 05 Apr, 2023 |
| Dana Aftab | Evp, Research And Development | 668,124 | 0 | 02 Mar, 2026 |
| Brenda Hefti | Svp And General Counsel | 119,631 | 0 | 02 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 24 Feb, 2026 | Michael Morrissey | Common Stock | D | 100,278 | $0.00 | 1,989,956 | I | G |
| 26 Feb, 2026 | Patrick J. Haley | Common Stock | A | 40,459 | $0.00 | 422,367 | D | A |
| 26 Feb, 2026 | Christopher J. Senner | Common Stock | A | 52,018 | $0.00 | 1,028,110 | D | A |
| 26 Feb, 2026 | Dana Aftab | Common Stock | A | 52,018 | $0.00 | 668,124 | D | A |
| 26 Feb, 2026 | Patrick J. Haley | Common Stock | A | 40,459 | $0.00 | 422,367 | D | A |
| 26 Feb, 2026 | Brenda Hefti | Common Stock | A | 23,119 | $0.00 | 119,631 | D | A |
| 26 Feb, 2026 | Brenda Hefti | Common Stock | A | 23,119 | $0.00 | 119,631 | D | A |
| 26 Feb, 2026 | Christopher J. Senner | Common Stock | A | 52,018 | $0.00 | 1,028,110 | D | A |
| 26 Feb, 2026 | Michael Morrissey | Common Stock | A | 160,437 | $0.00 | 1,614,552 | D | A |
| 24 Feb, 2026 | Dana Aftab | Common Stock | D | 47,918 | $44.50 | 616,106 | D | S |
| 19 Feb, 2026 | Dana Aftab | Common Stock | D | 29,873 | $44.35 | 664,024 | D | S |
| 13 Feb, 2026 | Christopher J. Senner | Common Stock | D | 34,278 | $43.00 | 1,042,579 | D | S |
| 13 Feb, 2026 | Michael Morrissey | Common Stock | A | 494,700 | $21.31 | 2,319,941 | D | M |
| 13 Feb, 2026 | Bob Oliver | Common Stock | A | 9,088 | $19.28 | 51,370 | D | M |
| 15 Feb, 2026 | Dana Aftab | Common Stock | D | 26,485 | $43.92 | 706,617 | D | F |
| 15 Feb, 2026 | Brenda Hefti | Common Stock | D | 5,430 | $43.92 | 115,181 | D | F |
| 15 Feb, 2026 | Patrick J. Haley | Common Stock | D | 31,483 | $43.92 | 449,722 | D | F |
| 13 Feb, 2026 | Bob Oliver | Common Stock | A | 9,088 | $19.28 | 51,370 | D | M |
| 13 Feb, 2026 | Christopher J. Senner | Common Stock | D | 34,278 | $43.00 | 1,042,579 | D | S |
| 15 Feb, 2026 | Brenda Hefti | Common Stock | D | 5,430 | $43.92 | 115,181 | D | F |